文献速递慢性肾脏病水电解质与酸碱

慢性肾脏病患者急性口服钾负荷后利钠反应受损:一项随机对照试验

Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该安慰剂对照交叉试验纳入18名健康人和9名非糖尿病CKD G3b-G4期患者,给予急性口服氯化钾或枸橼酸钾40 mmol,伴或不伴6周赖诺普利预处理。健康人补钾后2小时尿钠排泄增加,而CKD患者无此反应;CKD患者补钾后血钾升高更明显。提示CKD患者钾诱导的利钠作用消失,口服钾负荷增加高钾血症风险。

要点

  • 健康人补钾后2小时尿钠排泄增加,CKD患者无此利钠反应。
  • CKD患者补钾后血钾升高幅度高于健康人,高钾血症风险增加。
  • eGFR与补钾后2小时尿钠排泄正相关,不受赖诺普利预处理影响。

核心结论

  • 在CKD患者中,钾诱导的利钠作用不发生,口服钾负荷伴随高钾血症风险增加。

研究设计与样本

  • 安慰剂对照交叉试验,纳入18名健康人和9名非糖尿病CKD G3b-G4期患者,比较急性口服氯化钾、枸橼酸钾(各40 mmol)或安慰剂,伴或不伴6周赖诺普利(10 mg/天)预处理。

主要发现

  • 健康人补钾后2小时尿钠排泄增加,CKD患者无此变化,且不受赖诺普利预处理影响。
  • eGFR与补氯化钾和枸橼酸钾后2小时尿钠排泄正相关,无论是否赖诺普利预处理。
  • CKD患者补钾后血钾高于健康人,不受赖诺普利预处理影响。

临床怎么用

  • CKD G3b-G4期患者口服补钾时需警惕高钾血症,应监测血钾。
  • 不能假定CKD患者通过补钾获得利钠获益。

局限性

  • 样本量小(健康人18名,CKD患者9名),为急性单次负荷研究,长期影响未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The health benefits of dietary potassium have been linked to potassium-induced natriuresis. However, it is unknown whether potassium loading in patients with chronic kidney disease (CKD) induces natriuresis and to what degree it increases plasma potassium. We hypothesize that potassium-induced natriuresis remains intact and that potassium loading is safe in patients with CKD. METHODS: In this placebo-controlled crossover study, 18 healthy individuals and 9 patients with non-diabetic CKD stage G3b-G4 received an acute oral load of potassium chloride (KCl), potassium citrate (K-cit) (40 mmol each) or placebo, either with or without 6 weeks of lisinopril (10 mg/day) pretreatment. Differences in placebo-subtracted plasma potassium and natriuresis between groups during 4-h follow-up were analysed using linear mixed models. RESULTS: In healthy individuals, but not in patients with CKD, urinary sodium excretion increased 2 h after potassium supplementation, independent of lisinopril pretreatment. Compared with patients with CKD, mean urinary sodium excretion in healthy individuals was 13 mmol [95% confidence interval (CI) 4-22; P = .005] and 13 mmol (95% CI 4-22; P = .006) higher 2 h after KCl and K-cit, respectively. Estimated glomerular filtration rate positively correlated with urinary sodium excretion 2 h after KCl and K-cit, both with and without lisinopril pretreatment. Plasma potassium after potassium supplementation was higher in patients with CKD than in healthy individuals independent of lisinopril pretreatment. CONCLUSIONS: These findings indicate that in CKD, potassium-induced natriuresis does not occur and oral potassium loading is accompanied by an increased risk of hyperkalaemia.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wouda RD, Karsten M, Michels EHA, et al. Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant. 2026. PMID: 41288308. doi:10.1093/ndt/gfaf238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。